Brain natriuretic peptide and cardioembolic stroke / 国际脑血管病杂志

Cardioembolic stroke (CES) is the most severe type of ischemic stroke, accounting for 14％ to 30％ of all ischemic strokes, tends to early recurrence, and has a high long-term recurrence rate and mortality. Therefore, early diagnosis of CES in patients with ischemic stroke is of great significance. Some studies have shown that brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are associated with CES. This article reviews the roles of BNP and NT-proBNP in early diagnosis and recurrence risk prediction of CES.